Additional Ventures-CTIP Device Innovation Award (Translational Accelerator)

About this program

Additional Ventures, often partnering with organizations such as the American Heart Association and the Life Sciences Research Foundation, funds a suite of targeted awards to accelerate translational devices, foundational science, and career development focused on improving outcomes for individuals with single ventricle heart disease. Programs include the Translational Accelerator AV‑CTIP Device Innovation Award (milestone‑driven funding up to $1M over ~3 years), the Single Ventricle Research Fund (Independent Investigator up to $600K; Career Development up to $300K, both over 3 years), the Catalyst to Independence Award (up to $1M over 5 years), AHA/AV Collaborative Sciences Awards (teams up to $2.25M over 3 years), $50K Expansion Awards, and an LSRF‑supported postdoctoral fellowship ($67K/year for three years). Eligibility is program‑specific but typically requires applications from academic institutions, research institutes, or companies (the device award is limited to U.S.‑based entities), principal investigators with doctoral degrees for most research awards (Career Development for postdoctoral/mentored investigators), and defined team compositions for certain awards (e.g., project lead and manager plus clinical and technical expertise for device awards; multidisciplinary co‑PIs for AHA/AV awards).